A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer.
Hirooka Y, Itoh A, Kawashima H, Hara K, Nonogaki K, Kasugai T, Ohno E, Ishikawa T, Matsubara H, Ishigami M, Katano Y, Ohmiya N, Niwa Y, Yamamoto K, Kaneko T, Nieda M, Yokokawa K, Goto H.
Hirooka Y, et al. Among authors: matsubara h.
Pancreas. 2009 Apr;38(3):e69-74. doi: 10.1097/MPA.0b013e318197a9e3.
Pancreas. 2009.
PMID: 19276867
Clinical Trial.